Location: Home
  • search
  • go
  • Relate News
  • 10/16/2024GSK's Submits Priority Review Application for BCMA ADC in China
  • 10/16/2024NHSA Issues the Notice on Regulating the Management of Externally-fill...
  • 10/16/2024China's New Policies On Foreign Investment In Healthcare And Biotechno...
  • 10/16/2024China Biopharma Tracker – Q3 2024 (PharmaDJ)
  • 10/15/2024AstraZeneca/Daiichi's Enhertu Approved in China as First HER2-directed...
  • 10/15/2024BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...
  • 10/15/2024Eli Lilly Invests $200M to Expand Chinese Manufacturing Facility for D...
  • 10/15/2024China Solicits Comments on Draft Compliance Guidelines for Pharmaceuti...
  • 10/15/2024Review of Online Drug Sales Growth in China 2021-2023
  • 10/11/2024Chinese Health Insurance Premium Income Up 4.5% in 2023
  • 10/11/2024Recent Executive Moves
  • 10/10/2024QuantumPharma's Subsidiary Ailux Biologics Partners with Janssen Biote...
  • 10/10/2024Eli Lilly Submits Chinese NDA for Its Anti-IL23 Antibody Mirikizumab
  • 10/10/2024Guangdong Aims to Boost Biopharma Sector to Over CNY 1 Trillion by 202...
  • 10/10/2024Mainland China's Pharmaceutical Sales to Reach $345B by 2033: BMI/Fitc...
  • 10/9/2024US Venture Capital Opens Funding Opportunities for China Biotech Firms
  • 10/9/2024SMEI: Chinese Terminal Drug Market Grew 5.2% in 2023
  • 10/9/2024IQVIA Releases the 2024 White Paper on Development Trends in China's O...
  • 10/8/2024MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...
  • 10/8/2024Innovent and Ask Pharm Enter Strategic Deal for Limertinib 
  • 10/8/2024Genor Biopharma to Merge with Eddingpharm in Strategic Reverse Takeove...
  • 10/8/2024Zephyrm Bioscience Files for IPO on HKSE with CICC as Sponsor
  • 10/8/2024China to Establish a Unified Mapping Database for Traceability Codes, ...
  • 10/8/2024BeiGene Launches Tevimbra in US, Enters Competitive PD-1 Inhibitor Mar...
  • 10/8/2024CSPC Announces Regulatory Milestones in China and the U.S.
  • 10/8/2024NRDL China: 2024 Outlook (Simon Kucher)
  • 10/3/2024WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT
  • 10/3/2024Recent Executive Moves
  • 10/2/2024China Introduces Credit System for Hospital and Pharmacy Staff to Curb...
  • 10/2/2024CDE Solicits Comments on the Proposed Technical Guidelines for Writing...
  • Page:17/354 Total number of articles:10618: [First][<<] [15] [16] [17] [18] [19] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group